25 XP   0   0   10

First Wave BioPharma Inc
Buy, Hold or Sell?

Let's analyse First Wave BioPharma Inc together

PenkeI guess you are interested in First Wave BioPharma Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of First Wave BioPharma Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about First Wave BioPharma Inc

I send you an email if I find something interesting about First Wave BioPharma Inc.

Quick analysis of First Wave BioPharma Inc (30 sec.)










What can you expect buying and holding a share of First Wave BioPharma Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.04
When do you have the money?
1 year
How often do you get paid?
31.3%

What is your share worth?

Current worth
$1.78
Expected worth in 1 year
$2.20
How sure are you?
46.9%

+ What do you gain per year?

Total Gains per Share
$0.47
Return On Investment
15.5%

For what price can you sell your share?

Current Price per Share
$3.02
Expected price per share
$0 - $4.58
How sure are you?
50%

1. Valuation of First Wave BioPharma Inc (5 min.)




Live pricePrice per Share (EOD)

$3.02

Intrinsic Value Per Share

$-40.35 - $-43.63

Total Value Per Share

$-38.57 - $-41.85

2. Growth of First Wave BioPharma Inc (5 min.)




Is First Wave BioPharma Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$3.6m-$5.7m$8.3m319.2%

How much money is First Wave BioPharma Inc making?

Current yearPrevious yearGrowGrow %
Making money-$3.9m-$4.1m$192.7k4.9%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of First Wave BioPharma Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

What can you expect buying and holding a share of First Wave BioPharma Inc? (5 min.)

Welcome investor! First Wave BioPharma Inc's management wants to use your money to grow the business. In return you get a share of First Wave BioPharma Inc.

What can you expect buying and holding a share of First Wave BioPharma Inc?

First you should know what it really means to hold a share of First Wave BioPharma Inc. And how you can make/lose money.

Speculation

The Price per Share of First Wave BioPharma Inc is $3.02. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of First Wave BioPharma Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in First Wave BioPharma Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.78. Based on the TTM, the Book Value Change Per Share is $0.11 per quarter. Based on the YOY, the Book Value Change Per Share is $1.30 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.01 per quarter.
Based on historical numbers we can estimate the returns while holding a share of First Wave BioPharma Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-2.02-67.1%-1.95-64.6%-1.93-63.8%-4.25-140.8%-3.21-106.3%
Usd Book Value Change Per Share0.165.3%0.113.5%1.3043.2%-0.05-1.6%0.061.8%
Usd Dividend Per Share0.000.0%0.010.4%0.093.0%111,276.473,684,651.2%69,547.792,302,907.0%
Usd Total Gains Per Share0.165.3%0.123.9%1.3946.2%111,276.423,684,649.6%69,547.852,302,908.8%
Usd Price Per Share4.20-2.19-0.90-1.39-1.78-
Price to Earnings Ratio-0.52--0.27-0.00--0.12--0.22-
Price-to-Total Gains Ratio26.24-29.62--0.52-6.11-3.47-
Price to Book Ratio2.36-2.05--0.23-0.35-1.00-
Price-to-Total Gains Ratio26.24-29.62--0.52-6.11-3.47-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.02
Number of shares331
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.01111,276.47
Usd Book Value Change Per Share0.11-0.05
Usd Total Gains Per Share0.12111,276.42
Gains per Quarter (331 shares)38.7436,832,494.39
Gains per Year (331 shares)154.98147,329,977.58
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
114141145147330041-63147329968
229281300294660081-126294659946
343422455441990122-189441989924
457563610589320163-252589319902
571703765736650203-315736649880
686844920883980244-378883979858
710098510751031310285-4411031309836
8114112512301178640325-5051178639814
9129126613851325970366-5681325969792
10143140715401473300406-6311473299770

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%1.011.00.08.3%1.019.00.05.0%1.031.00.03.1%1.031.00.03.1%
Book Value Change Per Share2.02.00.050.0%5.07.00.041.7%8.012.00.040.0%11.021.00.034.4%11.021.00.034.4%
Dividend per Share1.00.03.025.0%7.00.05.058.3%10.00.010.050.0%10.00.022.031.3%10.00.022.031.3%
Total Gains per Share3.01.00.075.0%8.04.00.066.7%12.08.00.060.0%15.017.00.046.9%15.017.00.046.9%

Fundamentals of First Wave BioPharma Inc

About First Wave BioPharma Inc

First Wave BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of targeted and non-systemic therapies for the treatment of patients with gastrointestinal diseases. Its product candidates include the biologic adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients; and niclosamide, an oral small molecule with anti-viral and anti-inflammatory properties. The company develops FW-COV, which is in Phase II clinical trials for the treatment of severe acute respiratory syndrome coronavirus 2 gastrointestinal infections; FW-UP, which is in Phase II clinical trials for the treatment ulcerative proctitis and ulcerative proctosigmoiditis; FW-ICI-AC for immune checkpoint inhibitor-associated colitis and diarrhea in advanced stage oncology patients; and FW-UC, which is in Phase Ib/IIa clinical trials for the treatment of ulcerative proctitis and ulcerative proctosigmoiditis. It also develops FW-CD, which has completed Phase I clinical trials for Crohn's disease; and adrulipase, an oral, non-systemic, and biologic capsule for the treatment of exocrine pancreatic insufficiency in patients with cystic fibrosis and chronic pancreatitis. The company was formerly known as AzurRx BioPharma, Inc. and changed its name to First Wave BioPharma, Inc. in September 2021. First Wave BioPharma, Inc. was incorporated in 2014 and is headquartered in Boca Raton, Florida.

Fundamental data was last updated by Penke on 2024-04-21 23:16:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of First Wave BioPharma Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit First Wave BioPharma Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare First Wave BioPharma Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of First Wave BioPharma Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-12.7%+12.7%
5Y-12.7%10Y-8.0%-4.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--200.1%+200.1%
TTM--216.8%+216.8%
YOY--288.3%+288.3%
5Y-12.7%-449.1%+436.4%
10Y-8.0%-605.5%+597.5%
1.1.2. Return on Assets

Shows how efficient First Wave BioPharma Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare First Wave BioPharma Inc to the Biotechnology industry mean.
  • -59.6% Return on Assets means that First Wave BioPharma Inc generated $-0.60 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of First Wave BioPharma Inc:

  • The MRQ is -59.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -72.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-59.6%TTM-72.0%+12.5%
TTM-72.0%YOY-64.9%-7.1%
TTM-72.0%5Y-73.1%+1.0%
5Y-73.1%10Y-62.6%-10.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-59.6%-13.3%-46.3%
TTM-72.0%-12.8%-59.2%
YOY-64.9%-11.7%-53.2%
5Y-73.1%-13.9%-59.2%
10Y-62.6%-15.7%-46.9%
1.1.3. Return on Equity

Shows how efficient First Wave BioPharma Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare First Wave BioPharma Inc to the Biotechnology industry mean.
  • -113.8% Return on Equity means First Wave BioPharma Inc generated $-1.14 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of First Wave BioPharma Inc:

  • The MRQ is -113.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -211.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-113.8%TTM-211.1%+97.2%
TTM-211.1%YOY-51.9%-159.2%
TTM-211.1%5Y-93.4%-117.7%
5Y-93.4%10Y-92.9%-0.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-113.8%-16.9%-96.9%
TTM-211.1%-16.1%-195.0%
YOY-51.9%-15.1%-36.8%
5Y-93.4%-19.3%-74.1%
10Y-92.9%-20.2%-72.7%

1.2. Operating Efficiency of First Wave BioPharma Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient First Wave BioPharma Inc is operating .

  • Measures how much profit First Wave BioPharma Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare First Wave BioPharma Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of First Wave BioPharma Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-7.1%+7.1%
5Y-7.1%10Y-4.4%-2.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--296.2%+296.2%
TTM--232.5%+232.5%
YOY--298.2%+298.2%
5Y-7.1%-492.1%+485.0%
10Y-4.4%-632.4%+628.0%
1.2.2. Operating Ratio

Measures how efficient First Wave BioPharma Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of First Wave BioPharma Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y0.071-0.071
5Y0.07110Y0.044+0.027
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.231-3.231
TTM-3.310-3.310
YOY-3.890-3.890
5Y0.0715.739-5.668
10Y0.0447.876-7.832

1.3. Liquidity of First Wave BioPharma Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if First Wave BioPharma Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.58 means the company has $1.58 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of First Wave BioPharma Inc:

  • The MRQ is 1.582. The company is able to pay all its short-term debts. +1
  • The TTM is 1.313. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.582TTM1.313+0.269
TTM1.313YOY0.580+0.733
TTM1.3135Y1.152+0.160
5Y1.15210Y1.167-0.015
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5823.890-2.308
TTM1.3134.173-2.860
YOY0.5805.344-4.764
5Y1.1526.126-4.974
10Y1.1676.448-5.281
1.3.2. Quick Ratio

Measures if First Wave BioPharma Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare First Wave BioPharma Inc to the Biotechnology industry mean.
  • A Quick Ratio of 1.18 means the company can pay off $1.18 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of First Wave BioPharma Inc:

  • The MRQ is 1.185. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 0.921. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ1.185TTM0.921+0.264
TTM0.921YOY0.334+0.587
TTM0.9215Y0.973-0.052
5Y0.97310Y1.033-0.060
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1853.514-2.329
TTM0.9213.998-3.077
YOY0.3345.380-5.046
5Y0.9736.105-5.132
10Y1.0336.404-5.371

1.4. Solvency of First Wave BioPharma Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of First Wave BioPharma Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare First Wave BioPharma Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.48 means that First Wave BioPharma Inc assets are financed with 47.7% credit (debt) and the remaining percentage (100% - 47.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of First Wave BioPharma Inc:

  • The MRQ is 0.477. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.557. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.477TTM0.557-0.081
TTM0.557YOY2.162-1.604
TTM0.5575Y1.007-0.449
5Y1.00710Y1.052-0.045
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4770.339+0.138
TTM0.5570.336+0.221
YOY2.1620.271+1.891
5Y1.0070.366+0.641
10Y1.0520.389+0.663
1.4.2. Debt to Equity Ratio

Measures if First Wave BioPharma Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare First Wave BioPharma Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 91.0% means that company has $0.91 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of First Wave BioPharma Inc:

  • The MRQ is 0.910. The company is very able to pay all its debts with equity. +2
  • The TTM is 1.666. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ0.910TTM1.666-0.756
TTM1.666YOY0.246+1.420
TTM1.6665Y0.827+0.839
5Y0.82710Y0.932-0.105
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9100.388+0.522
TTM1.6660.402+1.264
YOY0.2460.335-0.089
5Y0.8270.426+0.401
10Y0.9320.461+0.471

2. Market Valuation of First Wave BioPharma Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings First Wave BioPharma Inc generates.

  • Above 15 is considered overpriced but always compare First Wave BioPharma Inc to the Biotechnology industry mean.
  • A PE ratio of -0.52 means the investor is paying $-0.52 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of First Wave BioPharma Inc:

  • The EOD is -0.373. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.519. Based on the earnings, the company is expensive. -2
  • The TTM is -0.272. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.373MRQ-0.519+0.146
MRQ-0.519TTM-0.272-0.247
TTM-0.272YOY-0.001-0.271
TTM-0.2725Y-0.121-0.150
5Y-0.12110Y-0.223+0.102
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.373-2.264+1.891
MRQ-0.519-2.629+2.110
TTM-0.272-2.680+2.408
YOY-0.001-4.145+4.144
5Y-0.121-6.257+6.136
10Y-0.223-6.254+6.031
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of First Wave BioPharma Inc:

  • The EOD is -0.388. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.540. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.339. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.388MRQ-0.540+0.152
MRQ-0.540TTM-0.339-0.201
TTM-0.339YOY-0.086-0.252
TTM-0.3395Y-0.186-0.153
5Y-0.18610Y-0.362+0.176
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.388-2.973+2.585
MRQ-0.540-3.333+2.793
TTM-0.339-3.553+3.214
YOY-0.086-5.605+5.519
5Y-0.186-8.376+8.190
10Y-0.362-8.865+8.503
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of First Wave BioPharma Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.36 means the investor is paying $2.36 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of First Wave BioPharma Inc:

  • The EOD is 1.698. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.361. Based on the equity, the company is underpriced. +1
  • The TTM is 2.054. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.698MRQ2.361-0.663
MRQ2.361TTM2.054+0.307
TTM2.054YOY-0.233+2.286
TTM2.0545Y0.353+1.701
5Y0.35310Y1.001-0.648
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.6981.896-0.198
MRQ2.3612.115+0.246
TTM2.0542.093-0.039
YOY-0.2332.884-3.117
5Y0.3533.542-3.189
10Y1.0013.916-2.915
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of First Wave BioPharma Inc.

3.1. Institutions holding First Wave BioPharma Inc

Institutions are holding 4.071% of the shares of First Wave BioPharma Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-09-30Citadel Advisors Llc0.2619081859818590
2023-12-31Tower Research Capital LLC0.18150.000228362278408.2437
2023-12-31UBS Group AG0.09830153714531729.7619
2023-12-31Wells Fargo & Co0.000406250
2023-12-31Kathleen S. Wright Associates Inc.0.00010100
2023-12-31U.S. Bancorp0.00010100
2023-12-31State Street Corporation000-590-100
2023-12-31OMERS Administration Corp.000-1490-100
2023-09-30FMR Inc000-158-100
2023-12-31Cornerstone Planning Group LLC000-1-100
2023-12-31Vanguard Group Inc000-824-100
2023-12-31Geode Capital Management, LLC000-2117-100
2023-09-30First Manhattan Co. LLC000-1-100
2023-12-31Virtu Financial LLC000-2549-100
2023-12-31BlackRock Inc000-19-100
2023-12-31Advisor Group Holdings, Inc.000-50-100
2023-12-31HRT FINANCIAL LLC000-891-100
Total 0.54230.000286240+76902+89.2%

3.2. Funds holding First Wave BioPharma Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-03-31Vanguard Institutional Extnd Mkt Idx Tr0.2239045353712451.0328
2024-02-29Fidelity Extended Market Index0.10170205900
2024-02-29Fidelity Series Total Market Index0.0354071700
2023-12-31SSgA U.S. Extended Market Index Class I0.000205-1-16.6667
2024-03-31State St US Extended Mkt Indx NL Cl C0.00020500
2023-12-31SSgA U.S. Total Market Index Strategy00100
2024-03-31NT Ext Equity Mkt Idx Fd - L001-1-50
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T200100
2023-12-31NT Ext Equity Mkt Idx Fd - NL00100
2023-12-31Northern Trust Extended Eq Market Idx00100
Total 0.361407326+3710+50.6%

3.3. Insider Transactions

Insiders are holding 7.69% of the shares of First Wave BioPharma Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-04-01James SapirsteinSELL1744.23
2024-04-01Sarah RomanoSELL754.23
2024-03-15James SapirsteinSELL18874.96
2024-03-15Sarah RomanoSELL11204.96
2024-01-12James SapirsteinSELL1664.2
2024-01-12Sarah RomanoSELL984.2
2023-10-04James SapirsteinSELL1385.8
2023-10-04Sarah RomanoSELL835.8
2023-08-31Charles J CasamentoSELL3026
2023-07-03James SapirsteinSELL16730.8
2023-07-03Sarah RomanoSELL9830.8

4. Summary

4.1. Key Performance Indicators

The key performance indicators of First Wave BioPharma Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1600.106+51%1.304-88%-0.048+130%0.056+188%
Book Value Per Share--1.7791.293+38%-2.835+259%0.569+212%0.316+464%
Current Ratio--1.5821.313+21%0.580+173%1.152+37%1.167+35%
Debt To Asset Ratio--0.4770.557-14%2.162-78%1.007-53%1.052-55%
Debt To Equity Ratio--0.9101.666-45%0.246+270%0.827+10%0.932-2%
Dividend Per Share---0.011-100%0.091-100%111276.466-100%69547.791-100%
Eps---2.025-1.952-4%-1.928-5%-4.252+110%-3.211+59%
Free Cash Flow Per Share---1.945-1.590-18%-2.758+42%-2.341+20%-1.778-9%
Free Cash Flow To Equity Per Share--0.2070.290-29%-0.815+494%0.232-11%0.189+10%
Gross Profit Margin--0.9981.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---43.633--------
Intrinsic Value_10Y_min---40.348--------
Intrinsic Value_1Y_max---10.336--------
Intrinsic Value_1Y_min---10.156--------
Intrinsic Value_3Y_max---26.511--------
Intrinsic Value_3Y_min---25.401--------
Intrinsic Value_5Y_max---37.206--------
Intrinsic Value_5Y_min---34.925--------
Market Cap6116104.000-39%8505840.0004440251.000+92%1831995.920+364%2809529.582+203%3603659.866+136%
Net Profit Margin----0%-0%-0.1270%-0.0800%
Operating Margin----0%-0%-0.0710%-0.0440%
Operating Ratio----0%-0%0.071-100%0.044-100%
Pb Ratio1.698-39%2.3612.054+15%-0.233+110%0.353+569%1.001+136%
Pe Ratio-0.373+28%-0.519-0.272-48%-0.001-100%-0.121-77%-0.223-57%
Price Per Share3.020-39%4.2002.193+92%0.905+364%1.387+203%1.779+136%
Price To Free Cash Flow Ratio-0.388+28%-0.540-0.339-37%-0.086-84%-0.186-66%-0.362-33%
Price To Total Gains Ratio18.870-39%26.24329.624-11%-0.523+102%6.112+329%3.473+656%
Quick Ratio--1.1850.921+29%0.334+255%0.973+22%1.033+15%
Return On Assets---0.596-0.720+21%-0.649+9%-0.731+23%-0.626+5%
Return On Equity---1.138-2.111+85%-0.519-54%-0.934-18%-0.929-18%
Total Gains Per Share--0.1600.117+37%1.395-89%111276.418-100%69547.847-100%
Usd Book Value--3602929.0002619072.500+38%-5741886.250+259%1153251.400+212%639343.031+464%
Usd Book Value Change Per Share--0.1600.106+51%1.304-88%-0.048+130%0.056+188%
Usd Book Value Per Share--1.7791.293+38%-2.835+259%0.569+212%0.316+464%
Usd Dividend Per Share---0.011-100%0.091-100%111276.466-100%69547.791-100%
Usd Eps---2.025-1.952-4%-1.928-5%-4.252+110%-3.211+59%
Usd Free Cash Flow---3939378.000-3219463.000-18%-5586019.750+42%-4740979.550+20%-3600711.563-9%
Usd Free Cash Flow Per Share---1.945-1.590-18%-2.758+42%-2.341+20%-1.778-9%
Usd Free Cash Flow To Equity Per Share--0.2070.290-29%-0.815+494%0.232-11%0.189+10%
Usd Market Cap6116104.000-39%8505840.0004440251.000+92%1831995.920+364%2809529.582+203%3603659.866+136%
Usd Price Per Share3.020-39%4.2002.193+92%0.905+364%1.387+203%1.779+136%
Usd Profit---4100939.000-3953049.250-4%-4145754.750+1%-6907063.500+68%-5437791.625+33%
Usd Revenue----0%-0%103212.600-100%64507.875-100%
Usd Total Gains Per Share--0.1600.117+37%1.395-89%111276.418-100%69547.847-100%
 EOD+2 -6MRQTTM+18 -14YOY+19 -135Y+22 -1210Y+22 -12

4.2. Fundamental Score

Let's check the fundamental score of First Wave BioPharma Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.373
Price to Book Ratio (EOD)Between0-11.698
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.185
Current Ratio (MRQ)Greater than11.582
Debt to Asset Ratio (MRQ)Less than10.477
Debt to Equity Ratio (MRQ)Less than10.910
Return on Equity (MRQ)Greater than0.15-1.138
Return on Assets (MRQ)Greater than0.05-0.596
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of First Wave BioPharma Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5036.304
Ma 20Greater thanMa 503.497
Ma 50Greater thanMa 1004.900
Ma 100Greater thanMa 2004.881
OpenGreater thanClose3.140
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets6,883
Total Liabilities3,280
Total Stockholder Equity3,603
 As reported
Total Liabilities 3,280
Total Stockholder Equity+ 3,603
Total Assets = 6,883

Assets

Total Assets6,883
Total Current Assets4,956
Long-term Assets1,927
Total Current Assets
Cash And Cash Equivalents 3,712
Other Current Assets 1,244
Total Current Assets  (as reported)4,956
Total Current Assets  (calculated)4,956
+/-0
Long-term Assets
Property Plant Equipment 210
Goodwill 1,684
Long-term Assets Other 11
Long-term Assets  (as reported)1,927
Long-term Assets  (calculated)1,905
+/- 22

Liabilities & Shareholders' Equity

Total Current Liabilities3,133
Long-term Liabilities147
Total Stockholder Equity3,603
Total Current Liabilities
Short-term Debt 680
Short Long Term Debt 613
Accounts payable 554
Other Current Liabilities 830
Total Current Liabilities  (as reported)3,133
Total Current Liabilities  (calculated)2,676
+/- 457
Long-term Liabilities
Capital Lease Obligations 214
Long-term Liabilities  (as reported)147
Long-term Liabilities  (calculated)214
+/- 67
Total Stockholder Equity
Common Stock0
Retained Earnings -184,329
Other Stockholders Equity 187,931
Total Stockholder Equity (as reported)3,603
Total Stockholder Equity (calculated)3,603
+/-0
Other
Capital Stock0
Cash and Short Term Investments 3,712
Common Stock Shares Outstanding 1,561
Current Deferred Revenue1,070
Liabilities and Stockholders Equity 6,883
Net Debt -2,885
Net Invested Capital 4,216
Net Working Capital 1,823
Property Plant and Equipment Gross 283
Short Long Term Debt Total 827



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-31
> Total Assets 
0
0
0
6,686
6,309
6,577
5,586
6,754
5,424
8,764
6,836
5,480
5,248
11,739
8,578
7,469
9,612
9,436
8,903
8,184
6,862
16,722
12,924
17,983
13,777
12,424
11,790
8,825
3,927
4,645
5,440
5,534
4,328
5,927
6,883
6,8835,9274,3285,5345,4404,6453,9278,82511,79012,42413,77717,98312,92416,7226,8628,1848,9039,4369,6127,4698,57811,7395,2485,4806,8368,7645,4246,7545,5866,5776,3096,686000
   > Total Current Assets 
0
0
0
2,067
1,688
2,253
1,361
2,964
1,750
5,031
3,185
1,953
1,806
8,634
5,683
4,800
3,629
3,730
3,408
2,897
1,601
11,538
7,870
13,170
8,615
7,502
9,425
6,550
1,789
2,549
3,413
3,530
2,354
3,977
4,956
4,9563,9772,3543,5303,4132,5491,7896,5509,4257,5028,61513,1707,87011,5381,6012,8973,4083,7303,6294,8005,6838,6341,8061,9533,1855,0311,7502,9641,3612,2531,6882,067000
       Cash And Cash Equivalents 
0
0
0
582
169
1,355
129
1,774
532
3,829
2,946
573
574
7,420
4,428
1,114
1,311
1,550
176
1,630
985
11,369
6,062
12,026
8,074
7,211
8,249
5,695
1,155
1,657
1,363
2,064
1,236
3,292
3,712
3,7123,2921,2362,0641,3631,6571,1555,6958,2497,2118,07412,0266,06211,3699851,6301761,5501,3111,1144,4287,4205745732,9463,8295321,7741291,355169582000
       Short-term Investments 
0
0
0
57
44
34
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000344457000
       Net Receivables 
0
0
0
1,075
1,084
342
251
961
1,011
979
174
1,104
1,015
1,081
1,197
3,173
2,120
2,090
2,637
760
103
21
551
502
0
0
0
28
70
192
93
20
0
0
0
00020931927028000502551211037602,6372,0902,1203,1731,1971,0811,0151,1041749791,0119612513421,0841,075000
       Other Current Assets 
0
0
0
354
391
523
982
229
207
223
65
275
216
132
58
513
198
90
595
507
513
149
1,256
643
541
292
1,176
827
564
700
1,957
1,445
1,118
684
1,244
1,2446841,1181,4451,9577005648271,1762925416431,256149513507595901985135813221627565223207229982523391354000
   > Long-term Assets 
0
0
0
4,618
4,621
4,324
4,224
3,790
3,674
3,734
3,652
3,527
3,442
3,105
2,895
2,669
5,984
5,706
5,495
5,287
5,261
5,184
5,054
4,812
5,162
4,922
2,365
2,275
2,138
2,096
2,027
2,004
1,974
1,951
1,927
1,9271,9511,9742,0042,0272,0962,1382,2752,3654,9225,1624,8125,0545,1845,2615,2875,4955,7065,9842,6692,8953,1053,4423,5273,6523,7343,6743,7904,2244,3244,6214,618000
       Property Plant Equipment 
0
0
0
176
173
174
164
152
141
150
148
134
149
145
137
129
350
285
160
127
192
158
93
62
485
449
409
379
348
326
303
280
257
234
210
2102342572803033263483794094494856293158192127160285350129137145149134148150141152164174173176000
       Goodwill 
0
0
0
1,833
1,908
1,854
1,888
1,768
1,797
1,917
1,973
2,016
2,071
1,967
1,953
1,925
1,914
1,833
1,887
1,844
1,890
1,969
2,054
1,974
1,991
1,945
1,912
1,862
1,756
1,715
1,684
1,684
1,684
1,684
1,684
1,6841,6841,6841,6841,6841,7151,7561,8621,9121,9451,9911,9742,0541,9691,8901,8441,8871,8331,9141,9251,9531,9672,0712,0161,9731,9171,7971,7681,8881,8541,9081,833000
       Intangible Assets 
0
0
0
2,584
2,513
2,270
2,137
1,836
1,700
1,636
1,500
1,346
1,191
948
760
570
3,671
3,539
3,407
3,275
3,143
3,011
2,880
2,748
2,616
2,484
0
0
0
0
0
0
0
0
0
0000000002,4842,6162,7482,8803,0113,1433,2753,4073,5393,6715707609481,1911,3461,5001,6361,7001,8362,1372,2702,5132,584000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
46
28
29
70
44
44
34
34
56
40
0
0
0
0
000040563434444470292846000000000000000000000
> Total Liabilities 
0
0
0
10,316
11,728
15,812
17,952
3,541
3,953
4,120
4,041
3,819
4,149
4,111
3,046
2,996
6,664
6,234
4,286
5,143
7,659
2,657
15,565
3,581
6,740
19,394
19,612
18,065
18,117
6,925
2,698
2,821
3,446
2,648
3,280
3,2802,6483,4462,8212,6986,92518,11718,06519,61219,3946,7403,58115,5652,6577,6595,1434,2866,2346,6642,9963,0464,1114,1493,8194,0414,1203,9533,54117,95215,81211,72810,316000
   > Total Current Liabilities 
0
0
0
8,816
10,228
14,312
15,552
2,341
2,653
2,560
2,731
2,479
2,819
2,611
1,466
2,996
6,221
5,819
4,286
5,143
7,616
2,625
15,545
3,575
6,454
19,098
12,300
14,216
17,284
6,694
2,483
2,625
3,261
2,482
3,133
3,1332,4823,2612,6252,4836,69417,28414,21612,30019,0986,4543,57515,5452,6257,6165,1434,2865,8196,2212,9961,4662,6112,8192,4792,7312,5602,6532,34115,55214,31210,2288,816000
       Short-term Debt 
0
0
0
6,577
7,461
9,243
9,932
155
78
671
336
417
316
308
0
255
2,097
2,103
1,605
3,320
5,485
74
610
404
258
95
719
474
225
64
670
448
217
65
680
680652174486706422547471995258404610745,4853,3201,6052,1032,0972550308316417336671781559,9329,2437,4616,577000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
552
347
140
0
641
403
162
0
603
380
153
0
613
6130153380603016240364101403475520000000000000000000000
       Accounts payable 
0
0
0
409
917
1,271
1,486
1,072
1,342
773
1,288
705
1,382
1,489
1,144
2,202
2,798
2,710
2,217
1,322
1,597
1,461
1,559
1,441
4,450
18,448
2,682
3,450
3,966
3,583
720
470
1,591
579
554
5545791,5914707203,5833,9663,4502,68218,4484,4501,4411,5591,4611,5971,3222,2172,7102,7982,2021,1441,4891,3827051,2887731,3421,0721,4861,271917409000
       Other Current Liabilities 
0
0
0
818
801
2,898
3,215
1,113
1,233
1,116
1,107
1,357
1,122
814
322
538
1,326
1,006
464
501
26
9
13,377
9
71
71
8,015
10,292
13,093
3,047
1,094
1,707
30
11
830
83011301,7071,0943,04713,09310,2928,0157171913,3779265014641,0061,3265383228141,1221,3571,1071,1161,2331,1133,2152,898801818000
   > Long-term Liabilities 
0
0
0
1,500
1,500
1,500
2,400
1,200
1,300
1,560
1,310
1,340
1,330
1,500
1,580
2,457
443
414
3,821
4,642
44
31
19
7
286
296
7,311
3,850
833
231
214
197
185
166
147
1471661851972142318333,8507,31129628671931444,6423,8214144432,4571,5801,5001,3301,3401,3101,5601,3001,2002,4001,5001,5001,500000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
296
7,000
3,585
585
0
0
0
0
0
0
0000005853,5857,0002960000000000000000000000000
> Total Stockholder Equity
0
0
0
-3,630
-5,420
-9,235
-12,366
3,213
1,471
4,645
2,795
1,661
1,098
7,628
5,532
4,474
2,948
3,202
4,617
3,041
-797
14,065
-2,641
14,402
7,037
-6,970
-7,822
-9,240
-14,190
-2,280
2,742
2,713
882
3,279
3,603
3,6033,2798822,7132,742-2,280-14,190-9,240-7,822-6,9707,03714,402-2,64114,065-7973,0414,6173,2022,9484,4745,5327,6281,0981,6612,7954,6451,4713,213-12,366-9,235-5,420-3,630000
   Common Stock
0
0
0
0
1
1
1
1
1
1
1
1
1
2
2
2
2
3
3
3
3
3
3
7
8
1
1
2
2
0
0
0
0
1
0
01000022118733333322221111111110000
   Retained Earnings Total Equity000000-168,9390000000000000000000000000000
   Accumulated Other Comprehensive Income 00000-1,455-1,419-1,283-1,224-1,267-1,226-1,247-1,113-1,212-1,273-1,109-1,267-1,357-1,219-1,150-1,096-1,060-850-956-1,023-1,170-1,400-1,462-1,214-1,277-1,151-1,346000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
156,166
0
0
0
0
0
0
000000156,1660000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
2,532
4,254
6,099
6,103
27,561
28,567
34,182
35,319
36,599
39,563
49,612
50,124
53,139
61,386
65,969
68,576
72,103
73,124
93,240
93,835
118,693
120,585
137,028
147,305
155,571
156,166
163,722
171,276
175,317
177,675
183,505
187,931
187,931183,505177,675175,317171,276163,722156,166155,571147,305137,028120,585118,69393,83593,24073,12472,10368,57665,96961,38653,13950,12449,61239,56336,59935,31934,18228,56727,5616,1036,0994,2542,532000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-29
Gross Profit-29-29
 
Operating Income (+$)
Gross Profit-29
Operating Expense-15,742
Operating Income-15,771-15,771
 
Operating Expense (+$)
Research Development5,033
Selling General Administrative11
Selling And Marketing Expenses-29
Operating Expense15,7425,015
 
Net Interest Income (+$)
Interest Income7
Interest Expense--22
Other Finance Cost-44
Net Interest Income-15
 
Pretax Income (+$)
Operating Income-15,771
Net Interest Income-15
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-15,795-15,747
EBIT - interestExpense = -15,748
-15,795
-15,817
Interest Expense-22
Earnings Before Interest and Taxes (EBIT)-15,771-15,817
Earnings Before Interest and Taxes (EBITDA)-15,742
 
After tax Income (+$)
Income Before Tax-15,795
Tax Provision-0
Net Income From Continuing Ops-15,680-15,795
Net Income-15,795
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses15,771
Total Other Income/Expenses Net-2415
 

Technical Analysis of First Wave BioPharma Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of First Wave BioPharma Inc. The general trend of First Wave BioPharma Inc is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine First Wave BioPharma Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of First Wave BioPharma Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 3.36 < 3.835 < 4.58.

The bearish price targets are: .

Tweet this
First Wave BioPharma Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of First Wave BioPharma Inc. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

First Wave BioPharma Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of First Wave BioPharma Inc. The current macd is -0.55476387.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the First Wave BioPharma Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for First Wave BioPharma Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the First Wave BioPharma Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
First Wave BioPharma Inc Daily Moving Average Convergence/Divergence (MACD) ChartFirst Wave BioPharma Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of First Wave BioPharma Inc. The current adx is 27.87.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell First Wave BioPharma Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
First Wave BioPharma Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of First Wave BioPharma Inc. The current sar is 2.42.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
First Wave BioPharma Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of First Wave BioPharma Inc. The current rsi is 36.30. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
First Wave BioPharma Inc Daily Relative Strength Index (RSI) ChartFirst Wave BioPharma Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of First Wave BioPharma Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the First Wave BioPharma Inc price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
First Wave BioPharma Inc Daily Stochastic Oscillator ChartFirst Wave BioPharma Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of First Wave BioPharma Inc. The current cci is -68.22051514.

First Wave BioPharma Inc Daily Commodity Channel Index (CCI) ChartFirst Wave BioPharma Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of First Wave BioPharma Inc. The current cmo is -26.13073131.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
First Wave BioPharma Inc Daily Chande Momentum Oscillator (CMO) ChartFirst Wave BioPharma Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of First Wave BioPharma Inc. The current willr is -63.85542169.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that First Wave BioPharma Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
First Wave BioPharma Inc Daily Williams %R ChartFirst Wave BioPharma Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of First Wave BioPharma Inc.

First Wave BioPharma Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of First Wave BioPharma Inc. The current atr is 0.4542907.

First Wave BioPharma Inc Daily Average True Range (ATR) ChartFirst Wave BioPharma Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of First Wave BioPharma Inc. The current obv is 43,860,625.

First Wave BioPharma Inc Daily On-Balance Volume (OBV) ChartFirst Wave BioPharma Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of First Wave BioPharma Inc. The current mfi is 30.14.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
First Wave BioPharma Inc Daily Money Flow Index (MFI) ChartFirst Wave BioPharma Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for First Wave BioPharma Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2023-12-22RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-27ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-04RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-21MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside

6.3. Candlestick Patterns

First Wave BioPharma Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of First Wave BioPharma Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5036.304
Ma 20Greater thanMa 503.497
Ma 50Greater thanMa 1004.900
Ma 100Greater thanMa 2004.881
OpenGreater thanClose3.140
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of First Wave BioPharma Inc with someone you think should read this too:
  • Are you bullish or bearish on First Wave BioPharma Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about First Wave BioPharma Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about First Wave BioPharma Inc

I send you an email if I find something interesting about First Wave BioPharma Inc.


Comments

How you think about this?

Leave a comment

Stay informed about First Wave BioPharma Inc.

Receive notifications about First Wave BioPharma Inc in your mailbox!